West Virginia 2022 Regular Session

West Virginia House Bill HB3091

Introduced
1/12/22  

Caption

Requiring Compliance with Generally Accepted Standards of Care

Impact

The implementation of HB 3091 would significantly amend existing insurance statutes in West Virginia by establishing strict guidelines for coverage of mental health services. Specifically, it prohibits insurance companies from limiting benefits for chronic mental health conditions, requiring that treatment considerations adhere to generally accepted clinical standards. This could improve access to necessary care for individuals suffering from mental health issues, as insurers would be compelled to offer services that meet defined standards of medical necessity without arbitrary restrictions.

Summary

House Bill 3091 seeks to establish the Advance Mental Health and Addiction Parity Act in West Virginia. The bill mandates that group health insurance plans provide equitable coverage for mental health disorders in comparison to physical health conditions. Its intent is to ensure that policies do not impose treatment limitations or financial requirements on mental health benefits that are not equally applied to physical health benefits. This legislative measure emphasizes the importance of comprehensive health coverage, particularly in a time when mental health and substance use disorders are gaining recognition as critical health issues that warrant proper care and attention.

Sentiment

The reception surrounding HB 3091 is generally supportive among mental health advocates and healthcare professionals who argue that it addresses long-standing disparities in insurance coverage for mental health treatment compared to physical health. However, some insurance industry representatives have raised concerns about the potential financial implications for insurers and how the bill might complicate existing insurance frameworks. This highlights a divide between the desire for enhanced mental health resources and the fears regarding the cost-effectiveness of such mandates within the health insurance industry.

Contention

Notable points of contention include the bill's prohibition of discretionary clauses in insurance contracts. This aspect has drawn scrutiny from some quarters, as it could limit insurers' ability to manage claims and benefits flexibly. Additionally, the enforcement mechanisms, including civil penalties for non-compliance, raise issues about regulatory burdens on insurers. These conflicts suggest that while the bill aims to promote fairness and accessibility in mental health care, there are divergent views on how to best achieve these objectives within the healthcare ecosystem.

Companion Bills

No companion bills found.

Previously Filed As

WV S2564

Provides that for treatment of mental health and substance use disorders, payors would rely upon criteria which reflect generally accepted standards of care when developing coverage.

WV H7945

Provides that for treatment of mental health and substance use disorders, payors would rely upon criteria which reflect generally accepted standards of care when developing coverage.

WV SB646

relative to mental health standards of care.

WV HB4709

STANDARDIZED PRIOR AUTH ACT

WV SB601

Cybersecurity - Standards and Compliance - Alterations

WV HB957

Cybersecurity - Standards and Compliance - Alterations

WV HB0957

Cybersecurity - Standards and Compliance - Alterations

WV SB01004

An Act Concerning Compliance With Mental Health Parity Laws.

WV HB5004

Relating generally to PANS and PANDAS.

WV HB5349

Requiring the Public Employees Agency and other health insurance providers to provide mental health parity

Similar Bills

CA AB1612

Disposition of controlled substances.

MA H2227

Replacing archaic and stigmatizing language for substance use

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

MI HB4948

Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25

NJ S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1617

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1203

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.

NJ S2271

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.